Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schönlein nephritis in children

Aims: To clarify the role of mesangial fibrinogen deposition in crescentic Henoch-Schönlein nephritis (HSN). Methods: A retrospective analysis of 21 children with HSN treated with immunosuppressants. Serial renal biopsies were performed before and after treatment. They were divided into two groups according to the immunofluorescent course of fibrinogen deposition: group I (n = 9), no or decreased deposition; group II (n = 12), persistent or increased deposition. Results: There were no differences between the two groups in renal manifestations or laboratory and histological findings at presentation. However, the activity index after immunosuppressive treatment was significantly decreased in group I (mean, 7.9 (SEM, 0.7) v 2.9 (0.4); p = 0.008) and unchanged in group II (mean, 6.8 (SEM, 0.3) v 6.0 (2.1)). The chronicity index was unchanged in group I, but increased in group II (mean, 0.8 (SEM, 0.3) v 1.8 (0.3); p = 0.02). Univariate analysis revealed that the only factor significantly related to persistent or increased fibrinogen deposition was age more than 9 years (p = 0.03). Furthermore, the intensity of fibrinogen deposition at the second biopsy correlated positively with the age at onset (R2 = 0.306; p = 0.009) and changes in the percentage of crescents (post-treatment crescents (%) minus pretreatment crescents (%)) correlated positively with the intensity of fibrinogen deposition at the second biopsy (R2 = 0.193; p = 0.046). Conclusions: This study indicates that fibrinogen deposition has an important role to play in renal injury of crescentic HSN and reflects persistent severe histological activity.

[1]  Y. Kawasaki,et al.  Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  J. Bergstein Glomerular fibrin deposition and removal , 2004, Pediatric Nephrology.

[3]  M. Nuutinen,et al.  Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis , 2003, Pediatric Nephrology.

[4]  P. Carmeliet,et al.  Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. , 2003, Journal of the American Society of Nephrology : JASN.

[5]  Y. Kawasaki,et al.  Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis. , 2003, Pediatrics.

[6]  D. Witte,et al.  Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. , 2001, American journal of physiology. Renal physiology.

[7]  I. T. Ten Berge,et al.  What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? , 2001, Kidney international.

[8]  C. Bernard,et al.  Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. , 2000, The Journal of pediatrics.

[9]  H. Tanaka,et al.  Age-related histologic alterations after prednisolone therapy in children with IgA nephropathy. , 1998, The Tohoku journal of experimental medicine.

[10]  P. Niaudet,et al.  Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis , 1998, Pediatric Nephrology.

[11]  Shori Takahashi,et al.  Pathological improvement of IgA nephropathy and Henoch‐Schönlein purpura nephritis with urokinase therapy , 1996, Acta paediatrica Japonica : Overseas edition.

[12]  S. Sasayama,et al.  Intraglomerular deposition of intact cross-linked fibrin in IgA nephropathy and Henoch-Schönlein purpura nephritis. , 1996, Nephron.

[13]  R. White,et al.  Long-term follow-up of childhood Henoch-Schönlein nephritis , 1992, The Lancet.

[14]  M. Endoh,et al.  Long-term effect of urokinase therapy in IgA nephropathy. , 1989, Clinical nephrology.

[15]  P. Tipping,et al.  PARTICIPATION OF CELL-MEDIATED IMMUNITY IN DEPOSITION OF FIBRIN IN GLOMERULONEPHRITIS , 1988, The Lancet.

[16]  K. Matsumoto,et al.  Glomerular deposition of cross-linked fibrin in human kidney diseases. , 1987, Kidney international.

[17]  P. Tipping,et al.  A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. , 1986, British journal of experimental pathology.

[18]  M. Endoh,et al.  Immunofluorescent studies on alpha 2-plasmin inhibitor (alpha 2-PI) in glomeruli from patients with IgA nephropathy. , 1985, Clinical and experimental immunology.

[19]  P. Tipping,et al.  Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. , 1985, The Journal of clinical investigation.

[20]  A. Morley,et al.  Cell proliferation within Bowman's capsule in mice , 1985, The Journal of pathology.

[21]  C. Chantler,et al.  Prognosis of Henoch-Schönlein nephritis in children. , 1977, British medical journal.

[22]  S. R. Meadow,et al.  Schönlein-Henoch nephritis. , 1972, The Quarterly journal of medicine.

[23]  D. Evans,et al.  The effect of defibrination on nephrotoxic serum nephritis in rabbits. , 1972, Clinical science.